Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
14.95
+1.00 (7.17%)
At close: Jun 16, 2025, 4:00 PM
15.54
+0.59 (3.92%)
After-hours: Jun 16, 2025, 7:59 PM EDT
Oscar Health Revenue
Oscar Health had revenue of $3.05B in the quarter ending March 31, 2025, with 42.20% growth. This brings the company's revenue in the last twelve months to $10.08B, up 54.26% year-over-year. In the year 2024, Oscar Health had annual revenue of $9.18B with 56.54% growth.
Revenue (ttm)
$10.08B
Revenue Growth
+54.26%
P/S Ratio
0.36
Revenue / Employee
$4,200,634
Employees
2,400
Market Cap
3.80B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
OSCR News
- 1 day ago - Oscar Health Could Be The Next Growth Monster With Tremendous Upside - Seeking Alpha
- 4 weeks ago - Oscar Health: Steep Budget Cuts In 2026 Healthcare Estimates Spell Uncertainty - Seeking Alpha
- 4 weeks ago - Oscar Health: The Healthcare Disruptor Just Hit Its Stride - Seeking Alpha
- 5 weeks ago - Oscar Health, Inc. (OSCR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance - Business Wire
- 2 months ago - Oscar Health, Inc. 2025 First Quarter Earnings Conference Call - Business Wire
- 3 months ago - Oscar Health: The Most Undervalued Small Cap But With One Big Risk - Seeking Alpha
- 3 months ago - Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A - Business Wire